Zhiyong Xiong

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Acute Myeloid Leukemia

Signaling Pathway

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (8) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (8) (2024)
Jian Shi, Daojia Miao, Qingyang Lv, Keshan Wang, Qi Wang, Huageng Liang, Hongmei Yang, Zhiyong Xiong, Xiaoping Zhang
The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling. Cell death & disease 14 (8) (2023)